NIH Seeks Exclusive License for Lysosomal Storage Disorder Treatment

Summary

The National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), is issuing a notice about a potential exclusive license for a treatment for Lysosomal Storage Disorders, as outlined in patent applications.